Praxis Has Unexpected Hits In Two Phase II Essential Tremor Studies

 
• By Joseph Haas
  
Surprise
Praxis surprised investors with positive data from two Phase III studies in essential tremor • Source: Shutterstock

More from Clinical Trials

More from R&D